TRAVERE THERAPEUTICS INC - NOTE 2.500% 9/1

Q2 2019 13F Holders as of 6/30/2019

Type / Class
Debt / NOTE 2.500% 9/1
Number of holders
35
Total Principal
219M
Shares change
+4.5M
Total reported value, excl. options
$198M
Value change
+$2.53M
Put/Call ratio
0
Number of buys
17
Number of sells
-11
Price
$0.90
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.